(19)
(11) EP 3 010 564 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
30.12.2020 Bulletin 2020/53

(45) Mention of the grant of the patent:
14.10.2020 Bulletin 2020/42

(21) Application number: 14813602.1

(22) Date of filing: 23.06.2014
(51) International Patent Classification (IPC): 
A61M 1/12(2006.01)
 A61F 2/24(2006.01)
(86) International application number:
PCT/CA2014/050598
(87) International publication number:
WO 2014/201575 (24.12.2014 Gazette 2014/52)

(54)

ARTIFICIAL VENTRICLES

KÜNSTLICHE VENTRIKEL

VENTRICULES ARTIFICIELS

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 21.06.2013 US 201313924472

(43) Date of publication of application:
27.04.2016 Bulletin 2016/17

(73) Proprietor: Dalian Corvivo Medical Technological Co. Ltd.
Dalian 116019 (CN)

(72) Inventors:
  • BIAN, Xiaoming
    Dalian, Liaoning 116011 (CN)
  • ZHENG, Frank
    Kirkland, Washington 98034 (US)

(74) Representative: Hertin und Partner Rechts- und Patentanwälte PartG mbB 
Kurfürstendamm 54/55
10707 Berlin
10707 Berlin (DE)


(56) References cited: : 
WO-A1-00/59560
US-A- 3 768 931
US-A- 5 332 403
US-A1- 2009 292 160
 WO-A2-2007/087014
US-A- 3 768 931
US-A- 5 332 403
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).